Selected article for: "artificial intelligence and disease course"

Author: Yu, Chaoran; Helwig, Ernest Johann
Title: Role of rehabilitation amidst the COVID-19 pandemic: a review
  • Cord-id: l0x10660
  • Document date: 2021_9_4
  • ID: l0x10660
    Snippet: COVID-19 remains globally a highly infectious disease targeting multiple organs. Rehabilitation is increasingly valued among the supportive care fields to combat COVID-19 as currently definitive curative treatment remains largely absent. This narrative review is to address rehabilitation related topics associated with the treatment of COVID-19 patients. Nosocomial spread remains a high risk for healthcare workers, with comparable high ratios of exposed workers suffering from the disease with mor
    Document: COVID-19 remains globally a highly infectious disease targeting multiple organs. Rehabilitation is increasingly valued among the supportive care fields to combat COVID-19 as currently definitive curative treatment remains largely absent. This narrative review is to address rehabilitation related topics associated with the treatment of COVID-19 patients. Nosocomial spread remains a high risk for healthcare workers, with comparable high ratios of exposed workers suffering from the disease with more severe clinical course. Primary principle of rehabilitation is to protect rehabilitation physicians and cover all person-to-person interactions. Translating perspectives are encouraged through each multidisciplinary approach. Rehabilitation for the outpatient remains a potential beneficial approach. Artificial intelligence can potentially provide aid and possible answers to important problems that may emerge involving COVID-19. The real value of rehabilitation in COVID-19 may be very impactful and beneficial for patient’s physical and mental health.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
    • ace inhibitor and adaptive immunity: 1
    • ace inhibitor and adipose tissue: 1
    • ace inhibitor and admission need: 1
    • ace inhibitor and admission rate: 1
    • ace inhibitor and long covid: 1, 2, 3
    • ace inhibitor and lung disease: 1
    • ace inhibitor and lung tissue: 1, 2, 3, 4
    • ace inhibitor and machine learning: 1
    • ace inhibitor and machine learning deep learning: 1
    • acute dyspnea and admission rate: 1, 2, 3
    • acute dyspnea and long covid: 1, 2
    • acute dyspnea and lung disease: 1, 2, 3, 4, 5, 6, 7, 8
    • acute dyspnea and lung tissue: 1, 2, 3
    • acute dyspnea and lung volume: 1
    • acute dyspnea and machine learning: 1
    • acute phase and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • acute phase and adipose tissue: 1
    • acute phase and admission rate: 1, 2